Detecting Alzheimer’s
When it Still Matters.
An AI-powered platform transforming routine clinical data, cognitive assessments, and MRI scans into actionable intelligence for early detection and personalized care.
The Challenge isn't Just the Disease
It's the Timing
Current diagnostics fail to capture the critical window for intervention.
Diagnostic Latency
Over 50% of cases are diagnosed too late, typically in moderate to advanced stages when treatments are least effective.
New Treatments
New Disease Modifying Treatments (DMTs) need:
- High-Sensitivity Screening
- Frequent, low-cost monitoring
- Sensitivity to slight changes in presymptomatic phase
Our Solution?
One Platform for all AD Stages
- Accurate Early Detection
- Continuous Follow-Up
- Precision Personalized Care
Two AI Models. Complete Clinical Coverage.
Bridging the gap from routine screening to precision diagnostics.
Routine Clinical Data Model
Deep Learning applied to standard clinical inputs (health history and cognitive assesment) to detect Alzheimer's risk and stratify patients for further evaluation.
- Accurate Screening
- Interpretable Clinical Results
MRI CNN Analysis
Advanced Convolutional Neural Networks (CNN) for objective analysis of MRI scans, identifying invisible structural biomarkers like hippocampal atrophy.
- Presymptomatic disease prediction
- Automated structural volumetry
Meet the Team
Restless innovators on a mission to reinvent Alzheimer’s diagnosis through cutting-edge Artificial Intelligence.
Daniele De Carli
Co-FounderEngineering Physics
Politecnico di Milano
Alberto Sudati
Co-FounderEngineering Physics
Politecnico di Milano
Ready to collaborate?
Whether you are a clinical center looking to adopt our technology, or a partner interested in our journey, we look forward to connecting.
Direct Contact
team@alzh-ai.com📍 Based in Milan, Italy